Page last updated: 2024-10-17

methylmalonic acid and Neurodevelopmental Disorders

methylmalonic acid has been researched along with Neurodevelopmental Disorders in 1 studies

Methylmalonic Acid: A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA.
methylmalonic acid : A dicarboxylic acid that is malonic acid in which one of the methylene hydrogens is substituted by a methyl group.

Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kvestad, I1
Hysing, M1
Shrestha, M1
Ulak, M1
Thorne-Lyman, AL1
Henjum, S1
Ueland, PM1
Midttun, Ø1
Fawzi, W1
Chandyo, RK1
Shrestha, PS1
Strand, TA1

Other Studies

1 other study available for methylmalonic acid and Neurodevelopmental Disorders

ArticleYear
Vitamin B-12 status in infancy is positively associated with development and cognitive functioning 5 y later in Nepalese children.
    The American journal of clinical nutrition, 2017, Volume: 105, Issue:5

    Topics: Adult; Asia; Child Development; Cognition; Cognitive Dysfunction; Female; Homocysteine; Humans; Infa

2017